Literature DB >> 11981303

Infection and disease caused by environmental mycobacteria.

Alimuddin Zumla1, John Grange.   

Abstract

Many species of mycobacteria that normally live as environmental saprophytes, the environmental mycobacteria (EM), are opportunist causes of disease in humans and animals. Many, but not all, cases are associated with some form of immune deficiency. An increasing number of species and clinical presentations are being described, and advances are being made in the understanding of the underlying predisposing factors. In recent years, four aspects of EM disease have become particularly relevant to human health: (1) the high prevalence of EM disease in patients with AIDS; (2) the emergence of Buruli ulcer, an ulcerative skin disease caused by Mycobacterium ulcerans, as the third most prevalent mycobacterial disease; (3) the effect of infection by EM on the immune responses to BCG vaccination and on the course and outcome of tuberculosis and leprosy; (4) the controversy over the involvement of mycobacteria, notably M. avium subspecies paratuberculosis, in human inflammatory bowel disease. These aspects change the status of EM from mere curiosities to important direct, indirect, and putative causes of serious and increasingly common human disease.

Entities:  

Mesh:

Year:  2002        PMID: 11981303     DOI: 10.1097/00063198-200205000-00003

Source DB:  PubMed          Journal:  Curr Opin Pulm Med        ISSN: 1070-5287            Impact factor:   3.155


  12 in total

1.  Generation of mucosal anti-human immunodeficiency virus type 1 T-cell responses by recombinant Mycobacterium smegmatis.

Authors:  Jae-Sung Yu; James W Peacock; Stacie Vanleeuwen; Tsungda Hsu; William R Jacobs; Mark J Cayabyab; Norman L Letvin; Richard Frothingham; Herman F Staats; Hua-Xin Liao; Barton F Haynes
Journal:  Clin Vaccine Immunol       Date:  2006-08-30

2.  Diversity of environmental Mycobacterium isolates from hemodialysis water as shown by a multigene sequencing approach.

Authors:  Margarita Gomila; Antonio Ramirez; Jorge Lalucat
Journal:  Appl Environ Microbiol       Date:  2007-04-20       Impact factor: 4.792

3.  Mycobacterial ecology of the Rio Grande.

Authors:  Christopher S Bland; Jamie M Ireland; Eduardo Lozano; Maria E Alvarez; Todd P Primm
Journal:  Appl Environ Microbiol       Date:  2005-10       Impact factor: 4.792

4.  Differential Immune Responses and Protective Effects in Avirulent Mycobacterial Strains Vaccinated BALB/c Mice.

Authors:  Laicheng Liu; Ruiling Fu; Xuefeng Yuan; Chunwei Shi; Shuling Wang; Xianyu Lu; Zhao Ma; Xiaoming Zhang; Weiyan Qin; Xionglin Fan
Journal:  Curr Microbiol       Date:  2015-05-21       Impact factor: 2.188

5.  Non-pathogenic Mycobacterium smegmatis induces the differentiation of human monocytes directly into fully mature dendritic cells.

Authors:  Angelo Martino; Alessandra Sacchi; Elisabetta Volpe; Chiara Agrati; Rafaella De Santis; Leopoldo Paolo Pucillo; Vittorio Colizzi; Silvia Vendetti
Journal:  J Clin Immunol       Date:  2005-07       Impact factor: 8.317

6.  Enhanced priming of adaptive immunity by Mycobacterium smegmatis mutants with high-level protein secretion.

Authors:  Natalie Taylor; Faith Bahunde; Afton Thompson; Jae-Sung Yu; William R Jacobs; Norm L Letvin; Barton F Haynes; Sunhee Lee
Journal:  Clin Vaccine Immunol       Date:  2012-07-11

7.  Isolation of non-tuberculous mycobacteria in children investigated for pulmonary tuberculosis.

Authors:  Mark Hatherill; Tony Hawkridge; Andrew Whitelaw; Michele Tameris; Hassan Mahomed; Sizulu Moyo; Willem Hanekom; Gregory Hussey
Journal:  PLoS One       Date:  2006-12-20       Impact factor: 3.240

8.  Intractable Cutaneous Nontuberculous Mycobacteriosis (Mycobacterium abscessus) during Treatment for Systemic Lupus Erythematosus.

Authors:  Dai Kishida; Mitsuto Sato; Chinatsu Kobayashi; Ken-Ichi Ueno; Tomomi Kinoshita; Minori Kodaira; Yasuhiro Shimojima; Wataru Ishii; Atsuhito Ushiki; Shu-Ichi Ikeda
Journal:  Intern Med       Date:  2017-05-15       Impact factor: 1.271

9.  Use of green fluorescent protein labeled non-tuberculous mycobacteria to evaluate the activity quaternary ammonium compound disinfectants and antibiotics.

Authors:  Claudia Cortesia; Teresita Bello; Gustavo Lopez; Scott Franzblau; Jacobus de Waard; Howard Takiff
Journal:  Braz J Microbiol       Date:  2016-10-11       Impact factor: 2.476

10.  Mycobacterium xenopi clinical relevance and determinants, the Netherlands.

Authors:  Jakko van Ingen; Martin J Boeree; Wiel C M de Lange; Wouter Hoefsloot; Saar A Bendien; Cecile Magis-Escurra; Richard Dekhuijzen; Dick van Soolingen
Journal:  Emerg Infect Dis       Date:  2008-03       Impact factor: 6.883

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.